TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Capra Science Antibodies AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
466
|
519
|
565 |
| Financial expenses |
3
|
1
|
1 |
| Earnings before taxes |
18
|
61
|
61 |
| EBITDA |
52
|
86
|
82 |
| Total assets |
351
|
428
|
322 |
| Current assets |
175
|
248
|
189 |
| Current liabilities |
88
|
167
|
141 |
| Equity capital |
229
|
214
|
180 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
3
|
3
|
4 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
65.2%
|
50.0%
|
55.9% |
| Turnover per employee |
155
|
173
|
141 |
| Profit as a percentage of turnover |
3.9%
|
11.8%
|
10.8% |
| Return on assets (ROA) |
6.0%
|
14.5%
|
19.3% |
| Current ratio |
198.9%
|
148.5%
|
134.0% |
| Return on equity (ROE) |
7.9%
|
28.5%
|
33.9% |
| Change turnover |
-55
|
0
|
42 |
| Change turnover % |
-10%
|
0%
|
8% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-25%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.